Boehringer Ingelheim at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
Boehringer Ingelheim brings 10 presentations to SCOPE 2027 in Orlando. Its sessions center on site selection strategy and on scaling risk-based quality management across a portfolio. Other topics include research site finances, a data framework for an AI-powered quality system and what real-world data can and cannot fix in trial design.
| Organization | SCOPE 2027 Attendance |
|---|---|
Boehringer Ingelheim Ingelheim, Germany | |
Family-owned pharmaceutical company with human and animal health medicines. | Panel Mon Mar 1 3:52pm–4:13pm KEYNOTE INTERACTIVE PANEL: SCOPE's 4th Annual Site Innovation Awards Site strategy and partnering Talk Tue Mar 2 11:05am–11:30am Talk Tue Mar 2 11:05am–11:30am Panel Tue Mar 2 12:20pm–12:45pm Talk Tue Mar 2 4:45pm–5:10pm Talk Wed Mar 3 9:00am–9:25am Panel Wed Mar 3 9:00am–9:50am Talk Wed Mar 3 11:40am–12:05pm Talk Wed Mar 3 12:15pm–12:30pm Panel Thu Mar 4 9:25am–9:50am Driving Clinical Trial Efficiency with Digital Measures Digital measures and eClinical technology |
Instantly find 20 buyers from Boehringer Ingelheim
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction